Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Detection of air trapping in chronic obstructive pulmonary disease by low frequency ultrasound.

Morenz K, Biller H, Wolfram F, Leonhadt S, Rüter D, Glaab T, Uhlig S, Hohlfeld JM.

BMC Pulm Med. 2012 Mar 16;12:8. doi: 10.1186/1471-2466-12-8.

2.

Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease.

Lee JS, Huh JW, Chae EJ, Seo JB, Ra SW, Lee JH, Kim EK, Lee YK, Kim TH, Kim WJ, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Sheen SS, Oh YM, Lee SD.

Clin Physiol Funct Imaging. 2012 Jan;32(1):12-8. doi: 10.1111/j.1475-097X.2011.01046.x. Epub 2011 Aug 18.

PMID:
22152074
3.

Severity-related differences in lung attenuation in men with COPD.

Torres I, Allona M, Martínez M, Lores V, Rojo B, García-Río F.

Arch Bronconeumol. 2010 Feb;46(2):56-63. doi: 10.1016/j.arbres.2009.09.013. Epub 2009 Nov 5. English, Spanish.

4.

Responsiveness to bronchodilator procaterol in COPD as assessed by forced oscillation technique.

Ito S, Uchida A, Isobe Y, Hasegawa Y.

Respir Physiol Neurobiol. 2017 Jun;240:41-47. doi: 10.1016/j.resp.2017.02.012. Epub 2017 Feb 24.

PMID:
28238903
5.

CT and functional respiratory tests. Evaluation of efficacy of bronchodilator therapy in chronic obstructive pulmonary disease (COPD).

Costantini AM, Sallustio G, Misciasci T, Corbo GM, Valente S, Pirronti T, Marano P.

Radiol Med. 2004 Jul-Aug;108(1-2):17-27. English, Italian.

PMID:
15269687
6.

Low frequency oscillometry parameters in COPD patients are less variable during inspiration than during expiration.

Kubota M, Shirai G, Nakamori T, Kokubo K, Masuda N, Kobayashi H.

Respir Physiol Neurobiol. 2009 Apr 30;166(2):73-9. doi: 10.1016/j.resp.2009.01.007. Epub 2009 Feb 6.

PMID:
19429522
7.

[Spirometric reversibility to salbutamol in chronic obstructive pulmonary disease (COPD). Differential effects on FEV1 and on lung volumes].

Manríquez J, Díaz O, Borzone G, Lisboa C.

Rev Med Chil. 2004 Jul;132(7):787-93. Spanish.

PMID:
15379324
8.

Partial versus maximal forced exhalations in COPD: enhanced signal detection for novel therapies.

Martinot JB, Chambellan A, Kays C, Silkoff PE, Guenard H.

Pulm Pharmacol Ther. 2014 Oct;29(1):58-65. doi: 10.1016/j.pupt.2014.03.004. Epub 2014 Mar 21.

PMID:
24661905
9.
10.

Acinar ventilation heterogeneity in COPD relates to diffusion capacity, resistance and reactance.

Jarenbäck L, Ankerst J, Bjermer L, Tufvesson E.

Respir Med. 2016 Jan;110:28-33. doi: 10.1016/j.rmed.2015.11.005. Epub 2015 Nov 11.

PMID:
26607879
11.

Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.

Schermer T, Heijdra Y, Zadel S, van den Bemt L, Boonman-de Winter L, Dekhuijzen R, Smeele I.

Respir Med. 2007 Jun;101(6):1355-62. Epub 2006 Nov 13.

12.

[Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease].

Rubin AS, Souza FJ, Hetzel JL, Moreira Jda S.

J Bras Pneumol. 2008 Jun;34(6):373-9. Portuguese.

13.

Quantitative assessment of air trapping in chronic obstructive pulmonary disease using inspiratory and expiratory volumetric MDCT.

Matsuoka S, Kurihara Y, Yagihashi K, Hoshino M, Watanabe N, Nakajima Y.

AJR Am J Roentgenol. 2008 Mar;190(3):762-9. doi: 10.2214/AJR.07.2820.

PMID:
18287450
14.

Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients.

Tzani P, Crisafulli E, Nicolini G, Aiello M, Chetta A, Clini EM, Olivieri D.

Int J Chron Obstruct Pulmon Dis. 2011;6:503-9. doi: 10.2147/COPD.S23746. Epub 2011 Oct 4.

15.

Dependence of bronchoconstrictor and bronchodilator responses on thoracic gas compression volume.

Pellegrino R, Antonelli A, Crimi E, Gulotta C, Torchio R, Dutto L, Pedersen OF, Brusasco V.

Respirology. 2014 Oct;19(7):1040-5. doi: 10.1111/resp.12349. Epub 2014 Jul 14.

16.

Forced expiratory capnography and chronic obstructive pulmonary disease (COPD).

Brown RH, Brooker A, Wise RA, Reynolds C, Loccioni C, Russo A, Risby TH.

J Breath Res. 2013 Mar;7(1):017108. doi: 10.1088/1752-7155/7/1/017108. Epub 2013 Feb 27.

17.

Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease.

Cazzola M, D'Amato M, Califano C, Di Perna F, Calderaro E, Matera MG, D'Amato G.

Clin Ther. 2002 Apr;24(4):595-604.

PMID:
12017404
18.

The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.

Walker PP, Calverley PM.

COPD. 2008 Jun;5(3):147-52. doi: 10.1080/15412550802092928.

PMID:
18568838
19.

Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD.

Dellacà RL, Pompilio PP, Walker PP, Duffy N, Pedotti A, Calverley PM.

Eur Respir J. 2009 Jun;33(6):1329-37. doi: 10.1183/09031936.00139608. Epub 2009 Jan 22.

20.

Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.

Ramlal SK, Visser FJ, Hop WC, Dekhuijzen PN, Heijdra YF.

Pulm Pharmacol Ther. 2014 Aug;28(2):158-64. doi: 10.1016/j.pupt.2013.09.002. Epub 2013 Sep 25.

PMID:
24076367

Supplemental Content

Support Center